Trevena, Inc. (TRVN) earnings
TRVN earnings moved a median of +4.77% by the close. Quarterly and annual TRVN reports and results, each read against the price at its own news timestamp. Back to the TRVN overview →
12 measured TRVN earnings events.
Where these TRVN earnings landedvs 12 measured TRVN earnings reactions
| Middle 50% of TRVN earnings reactions | +3.60% to +9.84% |
|---|---|
| Median reaction (to close) | +4.77% |
| Measured reactions | 12 |
Point-in-time · zero look-ahead
Half of the 12 TRVN earnings events with a measured close landed between +3.60% and +9.84%; 83% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form NT 10-K TREVENA INC For: Dec 31 | SEC filing · Form NT | +0.00% | +5.74% | |
| Form 10-Q TREVENA INC For: Sep 30 | SEC filing · Form 10-Q | +0.00% | +12.29% | |
| Trevena Reports Third Quarter 2024 Results and Provides Business Update | Press release | +0.00% | +12.29% | |
| Form 10-Q TREVENA INC For: Jun 30 | SEC filing · Form 10-Q | -0.67% | +9.84% | |
| Trevena Reports Second Quarter 2024 Results and Provides Business Update | Press release | -0.67% | +9.84% | |
| Form 10-Q TREVENA INC For: Mar 31 | SEC filing · Form 10-Q | +0.00% | +3.60% | |
| Trevena Reports First Quarter 2024 Results and Provides Business Update | Press release | +0.00% | +3.60% | |
| Form 10-K TREVENA INC For: Dec 31 | SEC filing · Form 10-K | -3.18% | -12.20% | |
| Trevena Reports Fourth Quarter 2023 Results and Provides Corporate Update | Press release | -3.18% | -12.20% | |
| Form 10-Q TREVENA INC For: Sep 30 | SEC filing · Form 10-Q | -1.46% | +4.19% | |
| Trevena Reports Third Quarter 2023 Results and Provides Business Update | Press release | -1.46% | +4.19% | |
| Trevena to Release Third Quarter 2023 Financial Results on November 14, 2023 | Press release | -1.79% | +5.36% |
Keep exploring
More TRVN: analyst actions → · SEC filings → · TRVN overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| HEMACARE CORP (HEMA) | 91 | 0.00% | 23% |
| Telesis Bio, Inc. (TBIO) | 91 | 0.00% | 40% |
| CV SCIENCES INC (CVSI) | 90 | +0.59% | 53% |
| Acasti Pharma, Inc. (ACST) | 89 | 0.00% | 44% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.